(Q36611791)

15 August 2017

Randomised study of adjuvant chemotherapy for completely resected p-stage I-IIIA non-small cell lung cancer (English)

1 reference

15 August 2017

1 reference

1 reference

K Nakagawa

1

1 reference

15 August 2017

H Tada

2

1 reference

15 August 2017

A Akashi

3

1 reference

15 August 2017

T Yasumitsu

4

1 reference

15 August 2017

K Iuchi

5

1 reference

15 August 2017

T Taki

6

1 reference

15 August 2017

K Kodama

7

1 reference

15 August 2017

Osaka Lung Cancer Study Group, Japan

8

1 reference

15 August 2017

language of work or name

English

0 references

publication date

12 September 2006

1 reference

15 August 2017

5

1 reference

British Journal of Cancer

inferred from page(s)

published in

1 reference

15 August 2017

95

1 reference

15 August 2017

7

1 reference

15 August 2017

817-821

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603336

15 August 2017

0 references

cites work

A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360551

Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non-Small-Cell Lung Cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360551

gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360551

Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360551

Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360551

DNA ploidy and proliferative activity in bcl-2 expressed non-small cell lung cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360551

DNA flow cytometric analysis in patients with operable non-small cell lung carcinoma

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360551

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360551

A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360551

A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancer.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360551

The relevance of flow-cytometric DNA content in the evaluation of lung cancer

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360551

Tables of the number of patients required in clinical trials using the logrank test.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360551

Nonparametric Estimation from Incomplete Observations

20 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603336

UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice

21 January 2018

1 reference

12 December 2020

Phase II study of UFT in patients with advanced non-small cell lung cancer

1 reference

12 December 2020

A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study). The Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan)

1 reference

12 December 2020

Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group

1 reference

12 December 2020

Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery

1 reference

12 December 2020

Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6603336

1 reference

Dimensions Publication ID

15 August 2017

1048039703

0 references

Fatcat ID

release_w4hnbh42nfbhlgxzatids2wuca

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/w4hnbh42nfbhlgxzatids2wuca

24 November 2022

mapped directly with Wikidata item

1 reference

15 August 2017

PubMed publication ID

16969350

1 reference